Board Members

William Browning, Secretary

Mr. Browning is an attorney with Browning|Hocker, representing small and large business as well as individuals in employment, insurance and business matters.  He has served as a Research Attorney with the San Diego Superior Court, an associate with the law firms McInnis Fitzgerald Rees & Sharkey and Seltzer, Caplan, Wilkins & McMahon, and a partner and co-chair of the Employment Practice Group at Klinedinst PC, prior to forming Browning|Hocker. Mr. Browning earned an MBA from San Diego State University, and worked in finance, management and manufacturing prior to his legal career. He has served on the Board since 2012.

Janet Roemer, Past Chair
Janet Roemer, Secretary

Ms. Roemer recently retired as Chief Operating Officer of Verenium, an industrial biotechnology company. Prior to that, she was a senior executive in the chemical industry and has extensive experience in the operational management of large scale, global businesses. Ms. Roemer holds a B.S. in chemistry from Miami University and an MBA from the University of Chicago. She has three grown children and enjoys travel, golf, and hiking with her dog. She joined the Board in 2015.

Marla Shepard, Treasurer
Marla Shepard

Ms. Shepard recently retired as the President & CEO of California Coast Credit Union. She has board experience with Jack Henry & Associates (publicly traded for-profit financial technology company) Compensation committee and Governance Chair, CA Credit Union League, Children's Miracle Network, SD Credit Unions PAC, Richard Myles Johnson Foundation. She has a business degree from Mesa College in Colorado. Ms. Shepard enjoys spending off-time in Alaska where she and her husband have owned a series of second homes hosting friends and family. Ms. Shepard has served on the Board since 2015.

William “Bill” Browning, M.D.
William “Bill” Browning, M.D.

Dr. Browning is MD who specializes in Orthopedic Surgery. He graduated from Dartmouth College with a BA in Chemistry; he attended Stanford University Medical School and completed his residency at the US Naval Hospital in Boston and Peter Bent Brigham Hospital, with a fellowship at the Children’s Hospital Medical Center in Boston. He has been an Orthopedist for the Kaiser Foundation Hospital for over 30 years and is a former Naval Aviator. He is married, with three grown children. He enjoys traveling and is a private pilot. He joined the Board in 2015.

Laura Clapper, M.D.
Dr. Laura Clapper, M.D.

Dr. Clapper is a Cigna Market Medical Executive for Southern California and Nevada where she is responsible for population health management, total medical cost and physician/provider relationships. She most recently served at Anthem as RVP Clinical Strategy and Medical Director for Provider Performance. Over her five years at Anthem, Dr. Clapper was responsible for client clinical strategy and innovation, and then most recently charged with Provider Enablement, and clinical oversight of all Anthem’s ACOs in California, inclusive of ‘Vivity’, Anthem’s Joint Venture with 7 hospital systems in the Los Angeles area. Prior to Anthem, Dr. Clapper served as the Chief Medical Officer of OneHealth, a health technology company integrating mobile technology with care management to increase member engagement and create a differentiated care experience, implementing over 20 innovation initiatives with health plans and providers across the US. In addition, she worked at Sharp as Corporate Medical Director for Clinical Effectiveness and Innovation and before Sharp worked at Aetna in National Accounts for the West Region. Prior to Aetna, Dr. Clapper spent 13 years at Health Net in all lines of business as well as in a wide variety of roles and oversight. Senior Medical Director for Health Net, where she managed all elements of medical management and quality for the Southern California market. Through these roles with plans and the providers, Dr. Clapper focused on improving medical operations management, integration of Behavior Health and pharmacy and enhancing programs to provide patients with the highest quality of care. She received her AB degree in Human Biology and Health Policy from Stanford University, her Medical Degree from The Uniformed Services University School of Medicine in Bethesda, MD, and a Master’s in Public Policy and Health Economics from Claremont’s Drucker Business School. She completed her residency at the National Medical Center Bethesda, MD in Pediatrics and is Board Certified in Pediatrics and is a Certified Physician Executive (CPE). In addition, Dr. Clapper is currently a clinical assistant professor of pediatrics at the University of California San Diego. Dr. Clapper joined the Board in 2016.

Robert (Bob) Finzi
Robert (Bob) Finzi

Mr. Finzi is a Senior Advisor to Credit Suisse, serving on the Investment Committees of Credit Suisse Direct Equity Partners and Hudson Clean Energy. Previously he served as Managing Partner of the Sprout Group, Credit Suisse’s venture capital affiliate and a General Partner of Merrill Lynch Venture Capital, which was merged into Sprout in 1991. Mr. Finzi is a member of the Board of Trustees of the Foundation Fighting Blindness.  Mr. Finzi has a BS & MS in Industrial Engineering from Lehigh University, and an MBA from Harvard Business School. He has twin daughters, both college graduates, is fluent in Italian and his hobbies include fishing and cooking. Mr. Finizi has served on the Board since 2015.

Jean-Claude "JC" Kyrillos, Chair
JC Kyrillos

Jean-Claude "JC" Kyrillos serves as the SDBB Chairman effective January 1, 2020. He is a long-time medical device and digital health executive. Mr. Kyrillos is SVP and President of the Envista Holdings (NYSE:  NVST) KaVo Equipment operating company, which is a leading global solution provider to dental professionals of drill instruments, treatment units and imaging hardware and software. Mr. Kyrillos has 30 years of diversified business experience, including 20 years of executive leadership in the medical device industry serving acute care, homecare, and diagnostics including leadership roles with Becton Dickinson/CareFusion Corporation and Qualcomm Life. At Qualcomm, he was the SVP and GM of the healthcare division powering intelligent healthcare from hospital to home, including medical device information systems, connected pharmaceuticals, and predictive analytics. At BD/CareFusion, JC led the Alaris infusion pump division. Prior to that, JC served in various President and Senior Vice President roles at ResMed, Inc. Mr. Kyrillos serves as a student mentor for children who are the first generation from their family to attend college via A Bridge for Kids and the Georgetown Scholarship Program. He formerly served for many years on the Board of Directors for the Sharp Healthcare Foundation. He earned an MBA from Harvard Business School and a BA with Honors in History from Colgate University. Mr. Kyrillos joined the Board in 2016.

Eve Benton
Eve Benton

Ms. Benton is an entrepreneur and has experience managing both for-profit and non-profit organizations.  She is the founder and board member for Vehicles for Change, Inc. a non-profit that awards automobiles to individuals who have secured employment, but cannot afford to purchase a vehicle. Ms. Benton is graduate of the Harvard Business School and serves on the board for the Moores Cancer Center at UCSD, the Sanford Burnham Prebys Medical Discovery Institute and the Humane Society. Ms. Benton has lived in San Diego for five years. She and her husband are very involved in serving the community.

Wade D. Schwendemann, M.D.
Wade D. Schwendemann, M.D.

Dr. Schwendemann is an MD who specializes in Maternal-Fetal Medicine.  He graduated from Albion College in Albion, MI with a BA in Biology and Chemistry.  He attended medical school in Toledo, OH and completed a residency in Obstetrics and Gynecology at the University of Kentucky in Lexington, KY before his fellowship at the Mayo Clinic in Rochester, MN. Since completion in 2009, he has practiced with the San Diego Perinatal Center. In his spare time, he and his wife enjoy traveling and martial arts. Dr. Schwendemann has served on the Board since 2011.

Tum Vongsawad
Tum Vongsawad

Mr. Vongsawad, with over 25 years of experience in the financial services industry, is Chief Operating Officer of San Diego County Credit Union (SDCCU) – the largest locally-owned financial institution in San Diego, California.  He holds a bachelor’s degree in Economics from the University of California, Irvine and is a graduate of Pacific Coast Executive Banking School. Mr. Vongsawad is involved in community and church organizations as well as serving on national and local committees in the credit union industry.  He enjoys spending time with his wife and three sons in the mountains snow skiing and on the lakes water skiing.  Mr. Vongsawad has served on the Board since 2011. 

Ram Yalamanchili

Ram Yalamanchili is the co-founder at Lexent Bio, which is building novel liquid biopsy technologies to help change the way we manage cancer. In his previous experiences as an entrepreneur, Mr. Yalamanchili helped build a leading supply-chain finance bank with over 250 employees and 20 branches in India. He was the CEO/Founder of Push Computing, which pioneered predictive security and container technologies for mobile (acquired / IPO under MobileIron). Prior to that, he was an early engineer at VMware (top technology IPO - 2008) and architect for the ESXi product. ESXi hypervisor powers a majority of the cloud infrastructure today. He is currently an active investor and board member at several startups. Mr. Yalamanchili holds a B.S in Electrical Engineering (Hons) from Carnegie Mellon University, and a GCE Management Science from Stanford University. He joined the Board in 2018.

Tim Scott, Chair-Elect
Tim Scott

Mr. Scott is co-founder and CEO of TEGA Therapeutics, a glycobiology company focused on lysosomal storage disorders and recombinant heparan sulfates. He previously was co-founder and President of Pharmatek Laboratories, a contract development and manufacturing company (sold to Catalent Pharma Solutions in 2016). Prior to that, he was Senior Vice President at Active.com (IPO 2011). Mr. Scott serves on the Board of Avelas, a bioscience company working to create better outcomes for cancer patients with its activatable cell-penetrating peptide technology. He also serves on the board of DTx, a biotechnology company using fatty acid motifs to deliver RNA therapeutics. He previously served on the board of Zacharon Pharmaceuticals (sold to Biomarin 2014). Mr. Scott is Executive Board Chair of CONNECT, a non-profit organization helping to create and scale innovation companies in San Diego. He also serves on the board of BIOCOM, a non-profit organization supporting the needs of bio/pharma companies in California. At UC San Diego, he serves on the Dean's Advisory Council for the Division of Biological Sciences. In the community, Mr. Scott is chair-elect of the San Diego Blood Bank. He is a trustee for the La Jolla Playhouse, a Tony-award winning regional theatre. And he serves on the board of Outside the Lens, a non-profit providing photography and digital media programs for underserved youth. Mr. Scott earned his B.A. in Biochemistry from the University of California, San Diego. He earned his J.D. from the University of San Diego and is a member of the California Bar. Mr. Scott joined the Board in 2018.

Susan Stone, Ph.D.
Susan Stone, Ph.D.

Dr. Susan Stone is currently the Chief Executive Officer of Sharp Coronado Hospital and Senior Vice President of Hospital Laboratory Services for Sharp HealthCare. Dr. Stone joined Sharp HealthCare in 1986 holding numerous leadership positions including Chief Nursing Officer for two of Sharp’s seven hospitals.

Dr. Stone’s research has been featured in the peer reviewed Health Environments Research and Design Journal, she was a contributing author to the 2008 Patient-Centered Care Improvement Guide and she served on the Planetree International Board of Directors from 2013-2019. In recognition of Dr. Stone’s ongoing efforts to improve the lives of women and girls and her efforts to improve community wellness, she was named as the 2019 Soroptimist of Coronado Legend. She earned her Bachelor of Nursing Science at San Diego State University, a Master and Doctorate of Philosophy in Nursing Science at the University of San Diego and is a fellow of the American College of Healthcare Executives. Dr. Stone joined the Board in 2020.

Jamie Levine
Jamie Levine

Mr. Levine is CFO of Cidara Therapeutics, a San Diego-based biotechnology company developing novel anti-infectives including immunotherapies. Prior to that, he held senior executive and Board roles at two biotechnology companies, Sapphire Energy and Verenium Corporation, and was a Managing Director in the investment banking division of Goldman Sachs & Co. Mr. Levine holds a BA in Economics from Brandeis University and an MBA from the Wharton School of the University of Pennsylvania. He joined the Board in 2020.

Rena Bradham
Rena Bradham

Rena Bradham is a Global Marketing Executive. She has more than 24 years of experience in the medical device industry and a proven track record in global and domestic marketing, strategy development and execution, product development and launch excellence, and lifecycle management, as well as customer insights, product innovation, market development, sales and marketing communications, and training development.

Most recently, Ms. Bradham led the global marketing team at Qualcomm Life. In this role, she drove global strategic marketing including commercialization strategy, communications, brand, sales collateral and launch. Ms. Bradham also led a global marketing and strategy team for a .1B in revenue (Medication Management Solutions) division of Becton Dickinson. Before that, she held various executive and marketing leadership positions at companies including CareFusion, Smiths Medical, Intraluminal Therapeutics, and Boston Scientific. Her healthcare experience includes hospital, home care and direct to patient/consumer, in large companies and startups.

Ms. Bradham holds a double Bachelor of Arts in Economics and History from University of California, Los Angeles, and an MBA from Santa Clara University. Ms. Bradham joined the Board in 2020.

Nicholas Ecos
Nicholas Ecos

Nicholas (Nick) Ecos is CEO of Arcis Biotechnology, a developer of chemistry-based tools that simplify preparation of samples for molecular analysis. He was previously CEO of Biomatrica where he led the development of biomarker collection products and the subsequent sale of the company to Exact Sciences Corporation. He previously spent over 20 years with Life Technologies (now Thermo Fisher Scientific) as Vice President and General Manager of several global business units supplying pharma and diagnostics companies with instrument and reagent components for their gene and cell therapies and diagnostic systems. One such unit, in Oslo, Norway, provided reagents used in Kymriah®, the first FDA-cleared CAR-T cell therapy. Other roles included Vice President of Sales, Americas of Upstate Biotechnology (now Millipore Sigma) and, before that, General Manager, Latin America of Invitrogen (now Thermo Fisher Scientific). He holds an MBA from Harvard Business School and a B.S. from Ohio State University. Mr. Ecos joined the Board in 2020.

Lauren Silverman, Ph.D.

Dr. Silverman retired as a Managing Director of the Novartis Venture Fund in Cambridge, MA. Prior to joining NVF, she was Global Head of Oncology Research Operations for the Novartis Institutes for Biomedical Research, and Director of Business Development and Licensing at Pfizer and OSI Pharmaceuticals. Dr. Silverman was a founding scientist of Cadus Pharmaceuticals. She continues to provide consulting services in the biotechnology arena. Dr. Silverman is also very active in the non-profit community in the San Diego area with organizations such as the Bilateral Safety Corridor Coalition, The American Academy of Pediatrics, The Humane Society of San Diego, and Encinitas Coastal Rotary.

Dr. Silverman earned her Ph.D. in molecular biology from the University of Utah, followed by fellowships at Princeton and Memorial Sloan Kettering. Dr. Silverman joined the Board in 2020.